[ET Net News Agency, 4 November 2026] SBP GROUP (01177) rose 3% to HK$5.03.
It hits an intra-day high of HK$5.04, breaking above the 10-D SMA of HK$4.896, and an intra-day low of HK$4.815. The total shares traded was 44.47 million, with a value of HK$218.8m. The active buy/sell ratio is 65:35, with net buying turnover of HK$65.99m. CLSA LTD accounts for greatest net responsive buying turnover of HK$7.88m, with volume weighted average price of HK$4.906. BARCLAYS CAPITAL ASIA accounts for greatest net responsive selling turnover of HK$13.81m, with volume weighted average price of HK$4.933. The stock has risen a combined 4.4% over the past 3 consecutive trading days.
The Hang Seng Index now rose 256 points, or 1.1% to 23,782.
Basic Information| Nominal | 5.030 | % Chg | +2.97% |
| High | 5.040 | Low | 4.815 |
| Shares Tr | 44.47m | Turnover | 218.8m |
| 10-D SMA | 4.896 | %H.V | 40.045 |
| 20-D SMA | 5.136 | VWAP | 4.920 |
| 50-D SMA | 5.387 | RSI14 | 45.120 |
Status: Breaking above the 10-D SMA, active buy/sell ratio is 65:35, with net buying turnover of HK$65.99m, rising a combined 4.4% over the past 3 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| SBP GROUP (01177) | 5.030 | +2.97 |
| SIHUAN PHARM (00460) | 0.730 | +1.39 |
| GRAND PHARMA (00512) | 4.230 | -0.35 |
| HENGRUI PHARMA (01276) | 50.500 | -0.79 |
| LIVZON PHARMA (01513) | 24.020 | +1.09 |
| LUYE PHARMA (02186) | 1.600 | -0.31 |
| FOSUN PHARMA (02196) | 16.820 | -0.30 |
| SH PHARMA (02607) | 11.170 | +0.90 |
| CHINARES PHARMA (03320) | 4.655 | -0.75 |
| HANSOH PHARMA (03692) | 33.400 | +4.57 |
(ed)
Nominal 
